Evaluation of HbA1c from CGM traces in an Indian population.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Lausanne : Frontiers Research Foundation]
    • Subject Terms:
      Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 1*/diagnosis ; Diabetes Mellitus, Type 1*/epidemiology; Humans ; Glycated Hemoglobin ; Blood Glucose ; Blood Glucose Self-Monitoring/methods ; India/epidemiology
    • Abstract:
      Introduction: The development of continuous glucose monitoring (CGM) over the last decade has provided access to many consecutive glucose concentration measurements from patients. A standard method for estimating glycated hemoglobin (HbA1c), already established in the literature, is based on its relationship with the average blood glucose concentration (aBG). We showed that the estimates obtained using the standard method were not sufficiently reliable for an Indian population and suggested two new methods for estimating HbA1c.
      Methods: Two datasets providing a total of 128 CGM and their corresponding HbA1c levels were received from two centers: Health Centre, Savitribai Phule Pune University, Pune and Joshi Hospital, Pune, from patients already diagnosed with diabetes, non-diabetes, and pre-diabetes. We filtered 112 data-sufficient CGM traces, of which 80 traces were used to construct two models using linear regression. The first model estimates HbA1c directly from the average interstitial fluid glucose concentration (aISF) of the CGM trace and the second model proceeds in two steps: first, aISF is scaled to aBG, and then aBG is converted to HbA1c via the Nathan model. Our models were tested on the remaining 32 data- sufficient traces. We also provided 95% confidence and prediction intervals for HbA1c estimates.
      Results: The direct model (first model) for estimating HbA1c was HbA1c mmol/mol = 0.319 × aISF mg/dL + 16.73 and the adapted Nathan model (second model) for estimating HbA1c is HbA1c mmol/dL = 0.38 × (1.17 × ISF mg/dL ) - 5.60.
      Discussion: Our results show that the new equations are likely to provide better estimates of HbA1c levels than the standard model at the population level, which is especially suited for clinical epidemiology in Indian populations.
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
      (Copyright © 2023 Majumdar, Kalamkar, Dudhgaonkar, Shelgikar, Ghaskadbi and Goel.)
    • References:
      Diabetes Care. 2008 Aug;31(8):1473-8. (PMID: 18540046)
      Nat Methods. 2020 Mar;17(3):261-272. (PMID: 32015543)
      J Diabetes Sci Technol. 2009 May 01;3(3):429-38. (PMID: 20144279)
      J Diabetes Sci Technol. 2021 Mar;15(2):294-302. (PMID: 31910672)
      Diabetes Technol Ther. 2023 May;25(5):324-328. (PMID: 36790875)
      Acta Clin Belg. 2020 Apr;75(2):109-115. (PMID: 30596337)
      J Clin Endocrinol Metab. 1978 Sep;47(3):578-80. (PMID: 263311)
      Diabetes Care. 2017 Aug;40(8):994-999. (PMID: 28733374)
      Diabetes Care. 2018 Nov;41(11):2275-2280. (PMID: 30224348)
      Elife. 2021 Sep 13;10:. (PMID: 34515636)
      Diabetes Technol Ther. 2023 Feb;25(2):148-150. (PMID: 36130138)
      Diabetes Ther. 2020 Sep;11(9):2019-2027. (PMID: 32696267)
      J Diabetes Sci Technol. 2015 Nov 09;10(2):330-5. (PMID: 26553023)
      Nature. 2020 Sep;585(7825):357-362. (PMID: 32939066)
      Diabetes Technol Ther. 2014 May;16(5):303-9. (PMID: 24299302)
      Diabete Metab. 1979 Mar;5(1):57-61. (PMID: 446835)
      Diabetes Care. 2019 Apr;42(4):e60-e61. (PMID: 30728221)
      S Afr Med J. 1979 Mar 3;55(9):335-7. (PMID: 441895)
      Diabetes Care. 2017 Dec;40(12):1631-1640. (PMID: 29162583)
      Nouv Presse Med. 1979 Feb 10;8(7):513-7. (PMID: 461162)
      Diabetes Res Clin Pract. 2018 Jul;141:56-61. (PMID: 29673846)
      Diabetes Technol Ther. 2021 Apr;23(4):253-258. (PMID: 33253015)
      Diabetes. 1978 Feb;27(2):102-7. (PMID: 624438)
      J Clin Endocrinol Metab. 1977 May;44(5):859-64. (PMID: 858776)
    • Contributed Indexing:
      Keywords: average blood glucose concentration (aBG); average interstitial fluid glucose concentration (aISF); continuous glucose monitoring (CGM); glycated hemoglobin (HbA1c); type 2 diabetes (T2D)
    • Accession Number:
      0 (Glycated Hemoglobin)
      0 (Blood Glucose)
    • Publication Date:
      Date Created: 20231206 Date Completed: 20231207 Latest Revision: 20240229
    • Publication Date:
      20240229
    • Accession Number:
      PMC10694347
    • Accession Number:
      10.3389/fendo.2023.1264072
    • Accession Number:
      38053728